Pharmacy – AboutHealthTransparency.org

A new study, published in JAMA Internal Medicine, found that the estimated use of new cancer drugs without documented clinical benefit has substantially increased over…

Posts tagged as “Pharmacy”

Study Finds Increased Use of New Cancer Drugs Without Documented Clinical Benefit, With Major Cost Implications for Patients

CMS Issues Proposed Rule to Lower Out of Pocket Medicare Part D Prescription Drug Costs

Nearly 13 Million Adults Forgo Prescription Drugs Due to Cost and Out-of-Pocket Spending Burdens

AHRQ Study: Out-of-Pocket Prescription Expenses To Treat Opioid Use Disorders Are High

New Interim Rule to Improves Transparency and Oversight of Prescription Drug and Medical Costs

CMS Updates Opioid Prescribing Mapping Tools with 2019 Data

CMS Updates Provider Payment and Utilization Public Use Files with 2019 Data

Drug Rebates Impact Rising Prescription Drug Spending and Continue to Increase for High Cost Drugs Like Brand and Specialty

New NCQA Program Highlights Specialty Pharmacies for Commitment to Quality

Study Finds Within Individual Health Systems Black and White Patients Received Different Opioid Doses

Last of Cost-Effectiveness Data for Expensive Drugs Paid by Medicare

Report Finds Family Healthcare Costs Decreased Last Year

Prescription Drug Price Transparency Bill Moves Closer to Law

CO APCD Data In Action, New Data Available

Diagnostic Errors, Maternal Health Top ECRI’s 2020 Patient Safety Concerns

Oregon All Payer All Claims Data – New Data Available

CHIA Releases Second Study on Prescription Drug Use in Massachusetts